Literature DB >> 7759780

Circadian profile of serum melatonin in patients with Cushing's syndrome or acromegaly.

M Terzolo1, A Piovesan, A Alì, A Codegone, A Pia, G Reimondo, M Torta, P Paccotti, G Borretta, A Angeli.   

Abstract

We evaluated the 24-h profile of serum melatonin (MT) in 16 patients with Cushing's syndrome (11 pituitary- and 5 adrenal-dependent) aged 38.1 +/- 13.8 years and in 19 patients with acromegaly due to GH-secreting pituitary adenoma aged 52 +/- 11.9 years. Thirty-three healthy subjects aged 30 +/- 7 years and 26 healthy subjects aged 59 +/- 12 years served as age-matched controls for the two groups of patients, respectively. All the patients had active disease and were off treatment; none had overt hypopituitarism. Blood drawings were collected at 08:00, 12:00, 16:00, 20:00, 22:00, 24:00, 02:00, 04:00 and 06:00 h in controls and patients. Serum MT, cortisol, GH and IGF-I were measured by specific RIA kits and ACTH by IRMA. Cosinor rhythmometry was employed for chronobiological analysis. The acromegalic patients displayed, as a whole group, higher 24-h mean MT levels with respect to age-matched controls (M +/- SD: 52.9 +/- 14.6 vs 32.9 +/- 8.0 pg/ml, p < 0.01) with normally synchronized MT profiles in 11/19 patients. No correlation was apparent between MT and either GH (24-h mean) or IGF-I. In the patients with Cushing's syndrome the circadian profile of serum MT was maintained in 10/16 cases; serum MT levels were comparable to those of controls (48.8 +/- 14.0 vs 50.0 +/- 16.0 pg/ml, NS) without any difference between pituitary- and adrenal-dependent forms. No correlation was found between MT and either ACTH or cortisol levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759780     DOI: 10.1007/BF03349691

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Melatonin, pituitary function and stress in humans.

Authors:  G M Vaughan; S D McDonald; R M Jordan; J P Allen; R Bell; E A Stevens
Journal:  Psychoneuroendocrinology       Date:  1979-10       Impact factor: 4.905

2.  Decreased melatonin concentration in Cushing's syndrome.

Authors:  P Soszyński; J Stowińska-Srzednicka; A Kasperlik-Zatuska; S Zgliczyński
Journal:  Horm Metab Res       Date:  1989-12       Impact factor: 2.936

3.  Mathematical and statistical analysis of circadian rhythms.

Authors:  D S Minors; J M Waterhouse
Journal:  Psychoneuroendocrinology       Date:  1988       Impact factor: 4.905

4.  Effects of "jet lag" on hormonal patterns. II. Adaptation of melatonin circadian periodicity.

Authors:  M Fève-Montange; E Van Cauter; S Refetoff; D Désir; J Tourniaire; G Copinschi
Journal:  J Clin Endocrinol Metab       Date:  1981-04       Impact factor: 5.958

5.  Growth hormone responses to melatonin in man.

Authors:  G A Smythe; L Lazarus
Journal:  Science       Date:  1974-06-28       Impact factor: 47.728

6.  Melatonin Synthesis in the Pineal Gland: Effect of Light Mediated by the Sympathetic Nervous System.

Authors:  R J Wurtman; J Axelrod; J E Fischer
Journal:  Science       Date:  1964-03-20       Impact factor: 47.728

7.  The effects of exogenous melatonin on endocrine function in man.

Authors:  J Wright; M Aldhous; C Franey; J English; J Arendt
Journal:  Clin Endocrinol (Oxf)       Date:  1986-04       Impact factor: 3.478

8.  Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly.

Authors:  C Wüster; G Steger; A Schmelzle; J Gottswinter; H W Minne; R Ziegler
Journal:  Horm Metab Res       Date:  1991-03       Impact factor: 2.936

9.  Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.

Authors:  J Beck-Friis; J G Ljunggren; M Thorén; D von Rosen; B F Kjellman; L Wetterberg
Journal:  Psychoneuroendocrinology       Date:  1985       Impact factor: 4.905

10.  Suppression of human growth hormone secretion by melatonin and cyproheptadine.

Authors:  G A Smythe; L Lazarus
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  2 in total

1.  Twenty-four hour melatonin pattern in acromegaly: effect of acute octreotide administration.

Authors:  A A Sinisi; D Pasquali; A D'Apuzzo; D Esposito; T Venditto; T Criscuolo; A De Bellis; A Bellastella
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

Review 2.  The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids.

Authors:  Henrik Oster; Etienne Challet; Volker Ott; Emanuela Arvat; E Ronald de Kloet; Derk-Jan Dijk; Stafford Lightman; Alexandros Vgontzas; Eve Van Cauter
Journal:  Endocr Rev       Date:  2017-02-01       Impact factor: 19.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.